Management of acute hypertensive response in patients with intracerebral hemorrhage

Current Atherosclerosis Reports

Volumn 14, Issue 4, 2012, Pages 322-327

  Alqadri, Syeda L ^a   Qureshi, Adnan I ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Acute hypertensive response; Antihypertensive treatment; ATACH; ATACH II; Cerebral blood flow; Cerebral perfusion pressure; Hypertension; INTERACT; INTERACT 2; Intracerebral hemorrhage; Ischemic penumbra; Mean arterial pressure; Perihematoma

Indexed keywords

ANTIHYPERTENSIVE AGENT; BRAIN NATRIURETIC PEPTIDE; CATECHOLAMINE; LABETALOL; NICARDIPINE;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRAIN METABOLISM; CHRONIC DRUG ADMINISTRATION; CONTINUOUS INFUSION; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; HYPERTENSION; PROGNOSIS; RANKIN SCALE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANTIHYPERTENSIVE AGENTS; BRAIN; CEREBRAL HEMORRHAGE; HUMANS; HYPERTENSION;

EID: 84865585293     PISSN: 15233804     EISSN: 15346242     Source Type: Journal    
DOI: 10.1007/s11883-012-0255-y     Document Type: Article

References (29)

1. Shah QA, Ezzeddine MA, Qureshi AI. Acute hypertension in intracerebral hemorrhage: pathophysiology and treatment. J Neurol Sci. 2007;261:74-9. (Pubitemid 47313498)
2. Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage. Lancet. 2009;373:1632-44.
3. Sacco S, Marini C, Toni D, Olivieri L, Carolei A. Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry. Stroke. 2009;40:394-9.
4. Elliott J, Smith M The acute management of intracerebral hemorrhage: a clinical review. Anesth Analg. 2010;110:1419-27.
5. Vuylsteke A, Vincent JL, Payen de La Garanderie D, et al. Characteristics, practice patterns, and outcomes in patients with acute hypertension: European registry for Studying the Treatment of Acute hyperTension (Euro-STAT). Crit Care. 2011;15:R271.
6. Caplan LR. Intracerebral haemorrhage. Lancet. 1992;339:656-8.
7. Kazui S, Naritomi H, Yamamoto H, Sawada T, Yamaguchi T. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke. 1996;27:1783-7. (Pubitemid 26332505)
8. Zazulia AR, Diringer MN, Videen TO, et al. Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab. 2001;21:804-10. (Pubitemid 32613534)
9. Qureshi AI, Wilson DA, Hanley DF, Traystman RJ. No evidence for an ischemic penumbra in massive experimental intracerebral hemorrhage. Neurology. 1999;52:266-72. (Pubitemid 29059050)
10. Fainardi E, Borrelli M, Saletti A, et al. CT perfusion mapping of hemodynamic disturbances associated to acute spontaneous intracerebral hemorrhage. Neuroradiology. 2008;50:729-40.
11. Kim-Han JS, Kopp SJ, Dugan LL, Diringer MN. Perihematomal mitochondrial dysfunction after intracerebral hemorrhage. Stroke. 2006;37:2457-62. (Pubitemid 44454660)
12. Qureshi AI, Hanel RA, Kirmani JF, Yahia AM, Hopkins LN. Cerebral blood flow changes associated with intracerebral hemorrhage. Neurosurg Clin N Am. 2002;13:355-70.
13. Whitworth JA. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983-92. (Pubitemid 38296854)
14. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-72. (Pubitemid 37430158)
15. Qureshi AI. Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation. 2008;118:176-87.
16. Qureshi AI, Ezzeddine MA, Nasar A, et al. Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med. 2007;25:32-8. (Pubitemid 44869006)
17. Anderson CS, Huang Y, Arima H, et al. Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT). Stroke. 2010;41:307-12. The INTERACT trial was a randomized, active-control, parallel-Assignment study. The outcome demonstrated the safety and tolerability of maintaining systolic BP < 140 mmHg for 24 hours in patients who present within 6 hours of onset of symptoms of intercerebral hemorrhage. It is the pilot trial for INERACT 2.
18. Willmot M, Leonardi-Bee J, Bath PM High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension. 2004;43:18-24. (Pubitemid 38031905)
19. Dandapani BK, Suzuki S, Kelley RE, Reyes-Iglesias Y, Duncan RC. Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke. 1995;26:21-4.
20. Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1-5. (Pubitemid 27039454)
21. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation. 2007;116:e391-413.
22. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and theQuality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke. 2007;38:2001-23. (Pubitemid 46850654)
23. Antihypertensive treatment of acute cerebral hemorrhage. Crit Care Med 2010;38:637-48.
24. Qureshi AI, Palesch YY. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care. 2011;15:559-76. ATACH II trial is an ongoing, randomized, multicenter, parallel-Assignment, Phase III trial based on the ATACH trial. The study aims to prove the efficacy of aggressive treatment of systolic blood pressure <140 mmHg with IV Nicardipine in patients who present within 6 hours of symptom onset of intercerebral hemorrhage.
25. Qureshi AI. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH): rationale and design. Neurocrit Care. 2007;6:56-66. (Pubitemid 46424454)
26. Nishiyama T, Yokoyama T, Matsukawa T, Hanaoka K. Continuous nicardipine infusion to control blood pressure after evacuation of acute cerebral hemorrhage. Can J Anaesth. 2000;47:1196-201. (Pubitemid 32098995)
27. Sorimachi T, Fujii Y, Morita K, Tanaka R. Rapid administration of antifibrinolytics and strict blood pressure control for intracerebral hemorrhage. Neurosurgery. 2005;57:837-44.
28. Ohwaki K, Yano E, Nagashima H, Hirata M, Nakagomi T, Tamura A. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke. 2004;35:1364-7. (Pubitemid 38697459)
29. Delcourt C, Huang Y, Wang J, et al. The second (main) phase of an open, randomised, multicentre study to investigate the effectiveness of an intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT2). Int J Stroke. 2010;5:110-6. INTERACT 2 is a randomized, multicenter, parallel-Assignment, ongoing trial that assesses efficacy of treatment in maintaining systolic blood pressure <140 mmHg with IV anti-hypertensives in patients who present within 6 hours of symptom onset of intercerebral hemorrhage.